Treatment recommendation for advanced skin cancer
Advanced (unresectable or metastatic) melanoma.
18 Feb 2016
NICE final guidance recommending nivolumab as monotherapy for treating advanced skin cancer. Nivolumab called Opdivo, and manufactured by Bristol Myers Squibb is to be made available on the NHS as a treatment option for patients with advanced unresectable or metastatic melanoma. …more